Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Aspira Women’s Health Inc. (AWHL) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Aspira Women’s Health Inc. (AWHL), most recent 12 months reported: revenue $8.55M, net loss $10.01M, free cash flow -$7.04M. Latest balance sheet on file: liquid cash $477K, total debt $1.71M, net cash -$1.23M. From SEC filings. Others in In Vitro & In Vivo Diagnostic Substances: INTELLIA THERAPEUTICS, INC. · Alpha Teknova, Inc. · ImmuCell Corporation · Anbio Biotechnology · BIOMERICA, INC. · VolitionRx Limited · Insight Molecular Diagnostics Inc. · Celldex Therapeutics, Inc.

Stock screener

Watchlist